| GHRS |
GH Research PLC |
1.68b |
23.84 |
(2.49%) |
0.00 |
0.00% |
— |
— |
| KRSA |
Cyclerion Therapeutics, Inc. |
1.69b |
31.00 |
(16.64%) |
0.00 |
0.00% |
30.77% |
— |
| NBTX |
Nanobiotix S.A. - Sponsored ADR |
1.69b |
33.31 |
(0.45%) |
0.00 |
0.00% |
— |
— |
| NTLA |
Intellia Therapeutics, Inc. |
1.72b |
11.75 |
(3.37%) |
0.00 |
(672.16%) |
12.58% |
— |
| NVAX |
Novavax, Inc. |
1.75b |
10.63 |
0.28% |
0.00 |
(59.87%) |
(61.64%) |
— |
| SEPN |
Septerna, Inc. |
1.78b |
37.77 |
(0.94%) |
0.00 |
(24.51%) |
13,520.11% |
— |
| ZBIO |
Zenas BioPharma, Inc. |
1.79b |
26.95 |
(0.98%) |
0.00 |
0.00% |
— |
— |
| XNCR |
Xencor, Inc. |
1.79b |
23.80 |
(0.34%) |
0.00 |
(155.59%) |
(28.56%) |
— |
| ABSI |
Absci Corporation |
1.81b |
9.74 |
(5.89%) |
0.00 |
(7,756.37%) |
(62.28%) |
— |
| VIR |
Vir Biotechnology, Inc. |
1.81b |
10.66 |
(0.28%) |
0.00 |
(83.00%) |
1,495.93% |
— |
| FTRE |
Fortrea Holdings Inc. |
1.90b |
19.89 |
(0.65%) |
0.00 |
(3.18%) |
(2.09%) |
— |
| ZYME |
Zymeworks Inc. |
1.92b |
26.52 |
(1.08%) |
0.00 |
(404.00%) |
(69.78%) |
— |
| SRPT |
Sarepta Therapeutics, Inc. |
1.97b |
18.67 |
1.52% |
0.00 |
(6.93%) |
(20.44%) |
— |
| BHVN |
Biohaven Ltd. |
1.99b |
12.99 |
(1.52%) |
0.00 |
0.00% |
425.20% |
— |
| MRVI |
Maravai LifeSciences Holdings, Inc. |
1.99b |
7.60 |
(0.65%) |
0.00 |
(37.07%) |
(5.03%) |
0.26% |
| LKFT |
Lakefront Biotherapeutics - Sponsored ADR |
1.99b |
29.38 |
(3.23%) |
0.00 |
(6.81%) |
(52.22%) |
— |
| AGIO |
Agios Pharmaceuticals, Inc. |
2.00b |
32.58 |
(0.97%) |
0.00 |
(418.24%) |
140.58% |
— |
| MESO |
Mesoblast Limited |
2.01b |
15.12 |
(2.33%) |
0.00 |
(1,091.71%) |
(26.54%) |
— |
| URGN |
Urogen Pharma |
2.02b |
41.35 |
0.29% |
0.00 |
(51.73%) |
100.27% |
— |
| NUVB |
Nuvation Bio Inc. |
2.02b |
5.74 |
0.17% |
0.00 |
(88.19%) |
1,083.56% |
— |
| VCEL |
Vericel Corporation |
2.03b |
39.71 |
0.92% |
82.63 |
7.91% |
22.95% |
— |
| TRVI |
Trevi Therapeutics, Inc. |
2.09b |
14.41 |
(1.84%) |
0.00 |
0.00% |
— |
— |
| KOD |
Kodiak Sciences Inc. |
2.09b |
32.35 |
(2.62%) |
0.00 |
0.00% |
— |
— |
| PVLA |
Palvella Therapeutics, Inc. |
2.10b |
138.16 |
(5.42%) |
0.00 |
0.00% |
142.89% |
— |
| RXRX |
Recursion Pharmaceuticals, Inc. |
2.11b |
3.74 |
(3.86%) |
0.00 |
(945.92%) |
(15.08%) |
— |
| ADMA |
ADMA Biologics Inc |
2.13b |
9.38 |
(1.47%) |
13.03 |
32.98% |
8.04% |
— |
| NKTR |
Nektar Therapeutics |
2.14b |
57.06 |
(3.91%) |
0.00 |
(287.84%) |
(27.15%) |
— |
| OCUL |
Ocular Therapeutix, Inc. |
2.16b |
9.65 |
(1.73%) |
0.00 |
(579.10%) |
(8.14%) |
— |
| AUPH |
Aurinia Pharmaceuticals Inc |
2.21b |
16.44 |
(0.96%) |
6.88 |
100.84% |
19.76% |
— |
| PHVS |
Pharvaris N.V. |
2.30b |
32.02 |
(2.94%) |
0.00 |
0.00% |
— |
— |
| MLYS |
Mineralys Therapeutics, Inc. |
2.35b |
25.86 |
(2.75%) |
0.00 |
0.00% |
— |
— |
| VRDN |
Viridian Therapeutics, Inc. |
2.36b |
20.47 |
(0.92%) |
0.00 |
(544.06%) |
23,220.33% |
— |
| SLS |
SELLAS Life Sciences Group, Inc. |
2.37b |
11.61 |
(3.09%) |
0.00 |
0.00% |
— |
— |
| VERA |
Vera Therapeutics, Inc. |
2.40b |
32.54 |
(1.92%) |
0.00 |
0.00% |
— |
— |
| HRMY |
Harmony Biosciences Holdings, Inc. |
2.40b |
41.26 |
0.24% |
13.18 |
18.88% |
24.25% |
— |
| NRIX |
Nurix Therapeutics, Inc. |
2.45b |
23.01 |
(2.41%) |
0.00 |
(928.44%) |
(58.40%) |
— |
| CLDX |
Celldex Therapeutics, Inc. |
2.49b |
31.10 |
(1.21%) |
0.00 |
(33,883.77%) |
(88.27%) |
2.16% |
| IRON |
Disc Medicine, Inc. |
2.55b |
65.24 |
(1.46%) |
0.00 |
0.00% |
— |
— |
| BEAM |
Beam Therapeutics Inc. |
2.55b |
24.27 |
(1.58%) |
0.00 |
(55.45%) |
158.88% |
— |
| IMNM |
Immunome, Inc. |
2.56b |
21.41 |
(5.01%) |
0.00 |
0.00% |
16.74% |
— |
| GPCR |
Structure Therapeutics Inc. Sponsored ADR |
2.59b |
35.93 |
(0.25%) |
0.00 |
0.00% |
— |
— |
| MBX |
MBX Biosciences, Inc. |
2.67b |
53.63 |
(3.18%) |
0.00 |
0.00% |
— |
— |
| QURE |
uniQure N.V. |
2.67b |
38.23 |
(0.23%) |
0.00 |
(1,350.73%) |
30.24% |
— |
| NAMS |
NewAmsterdam Pharma Company N.V. |
2.72b |
22.58 |
(0.70%) |
0.00 |
(3,644.21%) |
(88.87%) |
— |
| PGEN |
Precigen, Inc. |
2.78b |
7.75 |
0.65% |
0.00 |
(392.81%) |
1,875.05% |
— |
| ZLAB |
Zai Lab Limited Unsponsored ADR |
2.85b |
24.98 |
(1.19%) |
0.00 |
(41.86%) |
5.10% |
— |
| DYN |
Dyne Therapeutics, Inc. |
3.14b |
16.03 |
(2.91%) |
0.00 |
0.00% |
— |
— |
| RCUS |
Arcus Biosciences, Inc. |
3.19b |
24.97 |
(1.32%) |
0.00 |
(393.16%) |
(55.34%) |
— |
| ELVN |
Enliven Therapeutics, Inc. |
3.31b |
44.75 |
(0.93%) |
0.00 |
0.00% |
— |
— |
| DNLI |
Denali Therapeutics Inc. |
3.36b |
20.39 |
(0.39%) |
0.00 |
(171.06%) |
194.68% |
— |
| ARQT |
Arcutis Biotherapeutics, Inc. |
3.39b |
26.92 |
2.47% |
122.36 |
6.15% |
76.11% |
— |
| IDYA |
IDEAYA Biosciences, Inc. |
3.55b |
36.69 |
0.19% |
0.00 |
(74.75%) |
901.18% |
— |
| TARS |
Tarsus Pharmaceuticals, Inc. |
3.55b |
75.69 |
(0.36%) |
0.00 |
(7.67%) |
105.17% |
— |
| LEGN |
Legend Biotech Corporation Sponsored ADR |
3.69b |
19.11 |
0.26% |
0.00 |
(7.20%) |
59.55% |
— |
| XENE |
Xenon Pharmaceuticals Inc. |
3.73b |
36.94 |
(2.94%) |
0.00 |
0.00% |
(8.15%) |
— |
| ACAD |
ACADIA Pharmaceuticals Inc. |
3.83b |
20.68 |
(6.76%) |
9.19 |
33.42% |
11.75% |
— |
| TLX |
Telix Pharmaceuticals Limited |
3.86b |
11.45 |
1.24% |
— |
— |
— |
— |
| CELC |
Celcuity, Inc. |
3.88b |
79.52 |
0.19% |
0.00 |
0.00% |
— |
— |
| RLAY |
Relay Therapeutics, Inc. |
3.91b |
17.47 |
(0.96%) |
0.00 |
(2,594.20%) |
(74.29%) |
— |
| TNGX |
Tango Therapeutics, Inc. |
4.15b |
24.92 |
1.18% |
0.00 |
0.00% |
48.29% |
— |
| ABCL |
AbCellera Biologics Inc. |
4.15b |
12.70 |
0.47% |
0.00 |
(248.82%) |
101.29% |
— |
| VKTX |
Viking Therapeutics, Inc. |
4.31b |
35.56 |
(3.24%) |
0.00 |
0.00% |
— |
— |
| EWTX |
Edgewise Therapeutics, Inc. |
4.41b |
39.34 |
(4.42%) |
0.00 |
0.00% |
— |
— |
| IOVA |
Iovance Biotherapeutics, Inc. |
4.90b |
11.00 |
1.85% |
0.00 |
(89.09%) |
34.55% |
— |
| DFTX |
Definium Therapeutics, Inc. |
4.94b |
36.17 |
(1.52%) |
0.00 |
0.00% |
— |
— |
| DNTH |
Dianthus Therapeutics, Inc. |
5.07b |
88.55 |
(2.38%) |
0.00 |
(10,096.95%) |
(60.77%) |
— |
| ERAS |
Erasca, Inc. |
5.08b |
14.25 |
(1.86%) |
0.00 |
0.00% |
— |
— |
| PTCT |
PTC Therapeutics, Inc. |
5.20b |
62.67 |
0.63% |
0.00 |
(3.80%) |
(42.84%) |
— |
| CRSP |
CRISPR Therapeutics AG |
5.39b |
54.23 |
(2.64%) |
0.00 |
(3,368.72%) |
(64.80%) |
— |
| COGT |
Cogent Biosciences, Inc. |
5.45b |
32.31 |
2.80% |
0.00 |
0.00% |
110.23% |
— |
| TVTX |
Travere Therapeutics, Inc. |
5.66b |
59.44 |
(1.95%) |
0.00 |
(7.35%) |
77.12% |
— |
| ORKA |
Oruka Therapeutics, Inc. |
5.69b |
84.46 |
(1.20%) |
0.00 |
0.00% |
— |
— |
| MIRM |
Mirum Pharmaceuticals, Inc. |
5.84b |
89.70 |
0.38% |
0.00 |
(139.18%) |
44.02% |
— |
| SRRK |
Scholar Rock Holding Corporation |
5.96b |
48.63 |
0.31% |
0.00 |
0.00% |
213.65% |
— |
| LGND |
Ligand Pharmaceuticals Incorporated |
6.09b |
301.52 |
0.83% |
30.12 |
67.88% |
54.89% |
2.04% |
| CGON |
CG Oncology, Inc. |
6.09b |
67.15 |
(1.76%) |
0.00 |
(3,602.68%) |
840.79% |
— |
| RYTM |
Rhythm Pharmaceuticals, Inc. |
6.77b |
98.66 |
0.36% |
0.00 |
(87.62%) |
53.51% |
— |
| BLTE |
Belite Bio, Inc. Sponsored ADR |
6.82b |
167.33 |
(1.25%) |
0.00 |
0.00% |
— |
— |
| IMVT |
Immunovant, Inc. |
7.11b |
33.30 |
(2.06%) |
0.00 |
0.00% |
— |
— |
| IONS |
Ionis Pharmaceuticals, Inc. |
7.39b |
44.50 |
1.57% |
0.00 |
(64.66%) |
(7.41%) |
— |
| SYRE |
Spyre Therapeutics, Inc. |
7.68b |
85.69 |
(0.99%) |
0.00 |
0.00% |
(81.84%) |
— |
| PRAX |
Praxis Precision Medicines, Inc. |
7.87b |
280.78 |
(0.36%) |
0.00 |
0.00% |
249.53% |
— |
| ABVX |
Abivax SA Sponsored ADR |
8.23b |
91.06 |
(4.02%) |
0.00 |
0.00% |
— |
— |
| PCVX |
Vaxcyte, Inc. |
8.47b |
56.21 |
(1.21%) |
0.00 |
0.00% |
— |
— |
| TGTX |
TG Therapeutics, Inc. |
8.80b |
57.43 |
(0.16%) |
18.89 |
55.22% |
76.08% |
— |
| PTGX |
Protagonist Therapeutics, Inc. |
8.88b |
141.86 |
3.92% |
116.99 |
29.40% |
34.81% |
— |
| CYTK |
Cytokinetics, Incorporated |
8.98b |
64.66 |
(1.52%) |
0.00 |
(1,321.12%) |
(21.07%) |
— |
| CAI |
Caris Life Sciences,�Inc. |
9.12b |
31.98 |
(0.90%) |
85.08 |
8.15% |
96.36% |
— |
| IBRX |
ImmunityBio, Inc. |
9.19b |
8.44 |
(2.31%) |
0.00 |
(598.56%) |
192.92% |
— |
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
9.33b |
65.92 |
(0.23%) |
0.00 |
(47.79%) |
16.13% |
— |
| KYMR |
Kymera Therapeutics, Inc. |
9.69b |
111.95 |
(2.88%) |
0.00 |
(285.33%) |
134.84% |
— |
| KRYS |
Krystal Biotech, Inc. |
10.21b |
345.82 |
0.34% |
41.86 |
54.82% |
22.63% |
— |
| AXSM |
Axsome Therapeutics, Inc. |
10.27b |
195.09 |
(0.48%) |
0.00 |
(24.68%) |
56.87% |
— |
| TECH |
Bio-Techne Corp |
11.38b |
72.61 |
0.06% |
62.06 |
14.97% |
(0.38%) |
0.37% |
| MDGL |
Madrigal Pharmaceuticals, Inc. |
11.86b |
516.56 |
0.65% |
0.00 |
(25.32%) |
149.04% |
— |
| BMRN |
BioMarin Pharmaceutical Inc. |
11.96b |
60.26 |
(1.78%) |
158.58 |
2.14% |
11.20% |
— |
| CORT |
Corcept Therapeutics Incorporated |
12.87b |
116.10 |
(2.03%) |
223.27 |
6.53% |
16.02% |
0.31% |
| HALO |
Halozyme Therapeutics, Inc. |
13.08b |
113.90 |
(1.15%) |
32.36 |
24.86% |
41.15% |
— |
| BBIO |
BridgeBio Pharma, Inc. |
13.10b |
65.57 |
(1.09%) |
0.00 |
(97.03%) |
202.39% |
— |
| SMMT |
Summit Therapeutics PLC |
13.12b |
15.61 |
(4.70%) |
0.00 |
0.00% |
(61.03%) |
— |